Results
9
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
9 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PHM | €92.65 | 11.6% | 152.0% | €1.6b | €86.40 | PE2592.7x | E44.1% | 0.7% | Pharmaceuticals & Biotech | ||
BKT | €8.23 | 0.7% | 46.4% | €7.4b | €8.98 | PB1.3x | E34.9% | 5.7% | Banks | ||
LIB | €1.71 | 1.8% | 66.0% | €36.2m | n/a | PE22.8x | E63.1% | 2.3% | Real Estate Management and Development | ||
SOL | €1.60 | 0% | -52.6% | €145.3m | €3.00 | PS0.4x | E70.8% | n/a | Capital Goods | ||
ACX | €9.71 | -0.5% | 0.3% | €2.4b | €13.03 | PE57.4x | E39.2% | 6.4% | Materials | ||
ROVI | €65.55 | 4.5% | 4.1% | €3.4b | €88.21 | PE20.3x | E15.8% | 1.7% | Pharmaceuticals & Biotech | ||
ECR | €3.54 | -0.1% | 43.1% | €323.2m | n/a | PE22.9x | E48.5% | 2.7% | Materials | ||
IZER | €9.70 | 0.4% | 7.3% | €269.0m | €12.15 | PE62.9x | E40.9% | n/a | Software | ||
GAM | €1.27 | 0% | -6.6% | €119.7m | €2.10 | PE13.2x | E20.3% | n/a | Capital Goods |